Bonafide Health has launched a Women's Daily Creatine & Collagen supplement, a multi-benefit finished formulation designed specifically for perimenopausal and menopausal women seeking support across cognitive function, skeletal muscle maintenance, skin integrity, and bone density.
The launch reflects a growing body of research connecting creatine monohydrate to neuroprotective and musculoskeletal benefits beyond athletic performance. Estrogen's role in endogenous creatine synthesis means declining hormone levels during perimenopause may reduce creatine availability in brain and muscle tissue — a mechanism that has prompted renewed clinical interest in targeted supplementation for this demographic. Collagen peptides, the second core ingredient, supply hydroxyproline-rich substrates shown in peer-reviewed studies to support dermal collagen density and bone matrix integrity, both of which deteriorate with estrogen withdrawal.
A Converging Market
The women's health supplement segment has become one of the fastest-moving areas in the broader nutraceutical space, with menopause-focused products drawing particular operator and investor attention. Consumer demand is being driven by a cohort of health-literate women aged 40 to 60 who are actively seeking evidence-positioned alternatives to or complements for hormone therapy. The decision to pair creatine — historically positioned as a sports-nutrition ingredient — with collagen in a single daily serving reflects a formulation strategy aimed at simplifying routines while addressing multiple structure-function claims in one SKU.
Bonafide Health, which markets clinician-developed, hormone-free women's health products, is positioning the launch as an extension of its science-first brand identity. The company has previously focused on botanical and bioidentical hormone alternatives for menopause symptom management, making this entry into the creatine and collagen ingredient categories a notable category expansion.
Operator Implications
For retailers and e-commerce operators, the product fits neatly into the growing "femtech nutrition" adjacency, where supplement purchasing is increasingly driven by life-stage targeting rather than general wellness. The combination of creatine and collagen in a single daily dose reduces the multi-product stacking behavior common among this consumer segment, which could support higher conversion and repeat-purchase rates on direct-to-consumer channels.
The broader creatine ingredient market has seen sustained growth as clinical evidence accumulates around cognitive endpoints — including memory and processing speed — in aging populations, making it an increasingly attractive functional anchor for non-sports applications. Pairing it with collagen peptides, a category already well established in the women's wellness supplement space, gives Bonafide Health a differentiated but scientifically grounded platform to compete in a crowded menopause-support segment.
Full dosing disclosures, clinical substantiation details, and distribution channels had not been released at time of publication.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
